Which pharmaceutical product launch was revolutionary for diabetes care by introducing the first GLP-1 receptor agonist for type 2 diabetes management?

In the rapidly evolving medical industry, product launches can make history and transform patient care. This trivia question tests your knowledge of a groundbreaking pharmaceutical product launch that changed the standard of care for a common chronic condition. Do you know your medical product history well enough to identify this landmark medication introduction?

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

• Byetta (exenatide) by Amylin Pharmaceuticals and Eli Lilly in 2005
• Lantus (insulin glargine) by Sanofi in 2000
• Metformin (Glucophage XR) by Bristol-Myers Squibb in 1995
• Januvia (sitagliptin) by Merck in 2006

Powered by AIPolls.Net — AI-powered real-time polling platform.